search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
58 SKIN BRIGHTENING


colorimetric method based on the reduction of a ferric TriPyridylTriaZine (TPTZ) complex to its ferrous form. It can give indications about the capability of a substance to protect against oxidant injury when compared to a well-known antioxidant compound.12


At low pH,


reduction of ferric tripyridyl triazine (Fe III TPTZ) complex to ferrous form can be monitored by measuring the change in absorption at 593 nm. The reaction is nonspecific, in that any half reaction that has lower redox potential, under reaction conditions, than that of ferric ferrous half reaction, will drive the ferrous (Fe III to Fe II) ion formation. The change in absorbance is therefore, directly related to the combined or ‘total’ reducing power of the electron donating antioxidants present in the reaction mixture. Larix sibirica and ascorbic acid (used as


control) were tested at two concentrations in water, using the FRAP assay. Data are reported as values of reducing power of ascorbic acid fixed to 100. When compared to ascorbic acid, Larix


sibirica used at the same concentration exert very good antioxidant properties, being the latter value 70% of the value shown by pure ascorbic acid. It can be noticed that the values resemble those obtained with the 0.1% solutions indicating that the extract may exert antioxidant capacities even at extreme low concentrations (Fig 3). The results indicate that Larix sibirica is


of relevant interest as an antioxidant for lightening applications.


Lightening activity


The lightening capability of Larix sibirica (pure substance) was evaluated at two concentrations in B16 melanocyte cell culture. Kojic acid and SAP (Sodium Ascorbyl Phosphate) were used as positive control and untreated cells as negative control. The cytotoxicity level of the tested products has been determined in human dermal fibroblast (HDF) culture cells using MTT assay. Results (mean ± standard deviation) are shown in Figure 4 and 5. The cytotoxicity test indicated that Larix


sibirica does not show any toxic effect whereas Kojic acid and SAP showed slightly toxic effect at the tested concentrations on HDF cells (Fig 4). Larix sibirica inhibited melanin


production up to 67% when compared to untreated cells. Inhibitory activity of the extract on melanin production had dose- dependent response (Fig 5).


Transcriptomic analysis


The mechanism of action on inhibition of melanin biosynthesis has been described on the melanocyte specific genes Tyr and Mift, and genes involved in melanosome


PERSONAL CARE EUROPE


120.00 100.00 80.00 60.00 40.00 20.00 0.00


Control


Kojic Ac


Kojic Ac. 1%


SAP 1%


SAP 2%


Larix Sibirica 0.025%


Figure 4: Evaluation of Larix sibirica effect on HDF viability (cytotoxicity test).


120.00 100.00 80.00 60.00 40.00 20.00 0.00


Control


Kojic Ac


Kojic Ac. 1%


SAP 1%


SAP 2%


Larix Sibirica 0.025%


Larix Sibirica


Figure 5: Evaluation of Larix sibirica effect on melanin concentration in melanocytes. B16 melanocytes were treated for a period of 36 hours. Concentration of melanin was determined by spectrophotometry at (l) 470nm.


structure and biogenesis Pmel17 and Mart1.13


Siberian Larch extract suppressed the


expression of Tyr, Mitf, Pmel17 and Mart. Mitf, a helix loop helix–leucine zipper (HLH– LZ) transcription factor, regulates transcription of key pigmentation genes, tyrosinase (Tyr), tyrosinase related protein-1 (Tyrp1), and tyrosinase related protein-2


n Pmel17 n Mart1 n Tyr n Mitf


140 120 100 80 60 40 20 0


C SL 50 SL 25


Figure 6: Effect of Siberian larch extract (SL) on specific pigmentation genes. Effect of Siberian Larch (SL) at 25 μg/mL or 50 μg/mL on Tyr, Mitf, Pmel17 and Mart1 mRNA expression levels as determined by real time RT-PCR. Untreated Melan-a cells were used as controls (C). Results represent the mean ± SD with n=3.


(Tyrp2)/Dct (dopachrome tautomerase), and is recognised as the master regulator of pigmentation genes. Pmel17 and Mart1, key melanosome structural component genes, are critical for trafficking, appropriate folding, polymerisation, and synthesis of early stage melanin in the melanosome. The results indicate that Siberian larch


reduces melanin content, at least in part, through the suppression of key pigmentation genes, Mitf and Tyr, and melanosome structural component genes, Pmel17 and Mart1. Altogether, the results support the lightening effect of Siberian larch extract by inhibition of melanin biosynthesis and melanosome biogenesis and structure.


DNA protection by Larix sibirica The comet assay, or single cell gel electrophoresis assay (SCGE), is a common technique for measurement of DNA damage in individual cells. Under an electrophoretic field, damaged cellular DNA is separated from intact DNA, yielding a classic ‘comet tail’ shape under the microscope. Human Dermal Fibroblasts (HDF) and Human Epidermal Keratinocytes (HEK) were used to evaluated DNA protection of the Siberian Larch extract versus untreated cells, as negative control and resveratrol (15µM) as positive control.


June 2019 Larix Sibirica


% Fold change in gene expression % Melanin content % Viability


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84